Frontiers Pharmacogenetics of pediatric acute lymphoblastic leukemia in Uruguay: adverse events related to induction phase drugs

Frontiers in Pharmacology Pharmacogenetics and Pharmacogenomics

Variants in vincristine pharmacodynamic genes involved in neurotoxic

ancestry informative markers - List of Frontiers' open access articles

Frontiers Adverse Reactions to Drugs of Special Interest in a Pediatric Oncohematology Service

Frontiers Prophylactic alpha blockers fail to prevent postoperative urinary retention following orthopaedic procedures: evidence from a meta-analysis and trial sequential analysis of comparative studies

PDF) Implementation of Pharmacogenetics to Individualize Treatment Regimens for Children with Acute Lymphoblastic Leukemia

Pediatric acute lymphoblastic leukemia

Frontiers in Pharmacology Pharmacogenetics and Pharmacogenomics

Pharmacotypes across the genomic landscape of pediatric acute lymphoblastic leukemia and impact on treatment response

The evolution of acute lymphoblastic leukemia research and therapy at MD Anderson over four decades, Journal of Hematology & Oncology

Frontiers Pharmacogenomics as a Tool to Limit Acute and Long-Term Adverse Effects of Chemotherapeutics: An Update in Pediatric Oncology

Cost-analysis of treatment of childhood acute lymphoblastic leukemia with asparaginase preparations: the impact of expensive chemotherapy